Proceedings of the National Academy of Sciences · 2013 · 198 citations · 18 references
MedicineCancer BiologyOncologyChemotherapyEpigeneticsMolecular OncologyCancer EpigeneticsChemotherapy ResistanceEpigenetic Regulation In CancerSignal Transduction In CancerTargeted Cancer TherapyTherapeutic ResistanceAlkylating Agent ResistanceDna Methylation ModulationDna MethyltransferasesEpigenetic Drug ResistanceN6-methyladenosine RegulationResistance To Targeted TherapyTargeted Resistance MechanismsTherapeutic Resistance Mechanisms
A hypoxic microenvironment induces resistance to alkylating agents by activating targets in the mammalian target of rapamycin (mTOR) pathway. The molecular mechanisms involved in this mTOR-mediated hypoxia-induced chemoresistance, however, are unclear. Here we identify the mTOR target N-myc downstream regulated gene 1 (NDRG1) as a key determinant of resistance toward alkylating chemotherapy, driven by hypoxia but also by therapeutic measures such as irradiation, corticosteroids, and chronic exposure to alkylating agents via distinct molecular routes involving hypoxia-inducible factor (HIF)-1alpha, p53, and the mTOR complex 2 (mTORC2)/serum glucocorticoid-induced protein kinase 1 (SGK1) pathway. Resistance toward alkylating chemotherapy but not radiotherapy was dependent on NDRG1 expression and activity. In posttreatment tumor tissue of patients with malignant gliomas, NDRG1 was induced and predictive of poor response to alkylating chemotherapy. On a molecular level, NDRG1 bound and stabilized methyltransferases, chiefly O(6)-methylguanine-DNA methyltransferase (MGMT), a key enzyme for resistance to alkylating agents in glioblastoma patients. In patients with glioblastoma, MGMT promoter methylation in tumor tissue was not more predictive for response to alkylating chemotherapy in patients who received concomitant corticosteroids.
18
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia et al. · New England Journal of Medicine · 2005 · 7.3K citations · Full text
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Frank Winkler, Sergey V. Kozin, Ricky T. Tong et al. · Cancer Cell · 2004 · 1.2K citations · Full text